Agilent stock rises on $950M Biocare Medical acquisition
Investing.com Gold reports: Agilent stock rises on $950M Biocare Medical acquisition. This is a premium/paywalled source, so the brief is based on headline and available metadata only.
Investing.com Gold reports: Agilent stock rises on $950M Biocare Medical acquisition. This is a premium/paywalled source, so the brief is based on headline and available metadata only.